EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Each year, EMD Serono invests roughly 20% of total sales in R&D

RESEARCH
RESEARCH

With close collaboration across the R&D teams, EMD Serono is strengthening its synergies to discover and advance innovative therapies that address high medical needs.

A GLOBAL EFFORT
A GLOBAL EFFORT

Our Research & Development Institute in Billerica, MA is one of four biopharmaceutical research hubs within the the global organization.

PARTNERING
PARTNERING

Partnering with other biotechnology / pharmaceutical companies, as well as academic institutions, is a core part of our strategy. It helps us to bring therapeutic innovations to patients more quickly.

Cindy, Vice President and Head, Immunology

Persistent Patient Emphasizer

Many years ago I received a personalized thank you note from a patient who had benefitted from our product. It must have been difficult to seek out my name, but they made the effort because we had made a difference. I still get goose bumps when I think about it.

And many of us have been, are, or will be patients. Having been through fertility treatments myself, I know what it means to be a patient. That fuels my persistence in my work.

For example, we had hit a major roadblock in a clinical program and I was deeply disappointed.  When the end of the day came, a few of us agreed to just go home and give it a fresh look in the morning.

We had every reason to believe the molecule should perform for patients, and we kept at it.  We identified the roadblock and pushed through.  We've been able to move that drug forward now--because we persisted in what we believed in and what drives us:  delivering benefit for our patients.

SERVICES